Mirum Pharmaceuticals Inc (MIRM)

NASDAQ
23.95
-0.05(-0.21%)
After Hours
23.95
0.00(0.00%)
- Real-time Data
  • Volume:
    388,026
  • Day's Range:
    23.59 - 24.36
  • 52 wk Range:
    17.32 - 30.55

MIRM Overview

Prev. Close
24
Day's Range
23.59-24.36
Revenue
49.15M
Open
23.8
52 wk Range
17.32-30.55
EPS
-1.29
Volume
388,026
Market Cap
882.51M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
365,704
P/E Ratio
-18.68
Beta
1.44
1-Year Change
28.01%
Shares Outstanding
36,848,110
Next Earnings Date
May 04, 2023
What is your sentiment on Mirum Pharmaceuticals?
or
Market is currently closed. Voting is open during market hours.

Mirum Pharmaceuticals Inc News

Mirum Pharmaceuticals Inc Company Profile

Mirum Pharmaceuticals Inc Company Profile

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of therapies for rare and orphan diseases. The Company's main focus is the development and commercialization of LIVMARLI (maralixibat) oral solution (Livmarli) and Volixibat. Its pipeline consists of rare pediatric indications for Livmarli and orphan adult indications for its second product candidate, Volixibat. Livmarli is an oral solution as a once-daily medicine for cholestatic pruritus in patients with Alagille syndrome (ALGS) one year of age and older. Volixibat, is an oral, minimally absorbed agent designed to inhibit ileal bile acid transporter (IBAT), for the treatment of adult patients with cholestatic liver diseases. The Company is developing volixibat for the treatment of intrahepatic cholestasis of pregnancy (ICP), primary sclerosing cholangitis (PSC), and primary biliary cholangitis (PBC).

Read More

Analyst Price Target

Average52.88 (+120.77% Upside)
High84.00
Low30.00
Price23.95
No. of Analysts8
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsSellStrong BuyBuyStrong BuyStrong Buy
SummaryNeutralStrong BuyStrong BuyStrong BuyStrong Buy